NCT03157167 2025-03-05An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)Navidea BiopharmaceuticalsPhase 1 Completed15 enrolled 12 charts
NCT03029988 2020-09-10An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.Navidea BiopharmaceuticalsPhase 1 Terminated3 enrolled 7 charts